Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration

Journal of Investigative Dermatology

Volumn 129, Issue 8, 2009, Pages 1954-1962

  Reines, Ilka ^a   Kietzmann, Manfred ^a   Mischke, Reinhard ^a   Tschernig, Thomas ^b   Lüth, Anja ^c   Kleuser, Burkhard ^c   Bäumer, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; FINGOLIMOD; GAMMA INTERFERON; INTERLEUKIN 6; SPHINGOSINE 1 PHOSPHATE; TOLUENE DIISOCYANATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; IN VITRO STUDY; LANGERHANS CELL; LYMPH NODE CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SKIN ALLERGY; SKIN SENSITIZATION;

EID: 67651098683     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.454     Document Type: Article

References (39)

1. Amano T, Takeda T, Yano H, Tamura T (2007) Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice. Br J Dermatol156:906-12
2. Baumer W, Krekeler S, DeVries VC, Niedorf F, Tschernig T, Kietzmann M (2006) Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis. Exp Dermatol 15:322-9
3. Baumer W, Seegers U, Braun M, Tschernig T, Kietzmann M (2004) TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cellattracting chemokines. Br J Dermatol 151:823-30
4. Baumer W, Sulzle B, Weigt H, De Vries VC, Hecht M, Tschernig T et al.(2005) Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis. Br J Dermatol 153:136-44
5. Chen T, Guo J, Yang M, Han C, Zhang M, ChenWet al. (2004) Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood103:413-21
6. Czeloth N, Bernhardt G, Hofmann F, Genth H, Forster R (2005) Sphingosine- 1-phosphate mediates migration of mature dendritic cells. J Immunol175:2960-7
7. Davis MD, Clemens JJ, Macdonald TL, Lynch KR (2005) Sphingosine 1- phosphate analogs as receptor antagonists. J Biol Chem 280:9833-41
8. Ehling G, Hecht M, Heusener A, Huesler J, Gamer AO, van Loveren H et al.(2005) An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: First round. Toxicology 212:60-8
9. Gollmann G, Neuwirt H, Tripp CH, Mueller H, Konwalinka G, Heufler C (2008) Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions. Int Immunol 20:911-23
10. Graler MH, Goetzl EJ (2004) The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 18:551-3
11. Herzinger T, Kleuser B, Schafer-Korting M, Korting HC (2007) Sphingosine-1- phosphate signaling and the skin. Am J Clin Dermatol 8:329-36
12. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A (2004) Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 122:673-84
13. Homey B, Assmann T, Vohr HW, Ulrich P, Lauerma AI, Ruzicka T et al.(1998) Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 160:5331-40
14. Hong JH, Youm JK, Kwon MJ, Park BD, Lee YM, Lee SI et al. (2008) K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca(2+) signaling. J Invest Dermatol128:2166-78
15. Idzko M, Hammad H, van Nimwegen M, Kool M, Muller T, Soullie T et al.(2006) Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 116:2935-44
16. Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y et al. (2002) Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 16:625-7
17. Kim DS, Kim SY, Kleuser B, Schafer-Korting M, Kim KH, Park KC (2004) Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal 16:89-95
18. Kimber I, Basketter DA, Gerberick GF, Dearman RJ (2002) Allergic contact dermatitis. Int Immunopharmacol 2:201-11
19. Kohno T, Tsuji T, Hirayama K, Watabe K, Matsumoto A, Kohno T et al. (2004) A novel immunomodulator, FTY720, prevents spontaneous dermatitis in NC/Nga mice. Biol Pharm Bull 27:1392-6
20. Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H et al.(1999) Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 9:65-77
21. Lan YY, De Creus A, Colvin BL, Abe M, Brinkmann V, Coates PT et al. (2005) The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 5:2649-59
22. Lutz MB, Kukutsch N, Ogilvie L, Rossner S, Koch F, Romani N et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92
23. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J et al.(2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346-9
24. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V et al.(2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-60
25. Muller H, Hofer S, Kaneider N, Neuwirt H, Mosheimer B, Mayer G et al.(2005) The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol 35:533-45
26. Nakashima D, Kabashima K, Sakabe J, Sugita K, Kobayashi T, Yoshiki T et al.(2008) Impaired initiation of contact hypersensitivity by FTY720. J Invest Dermatol 128:2833-41
27. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J et al. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-88
28. Ortner U, Inaba K, Koch F, Heine M, Miwa M, Schuler G et al. (1996) An improved isolation method for murine migratory cutaneous dendritic cells. J Immunol Methods 193:71-9
29. Panhans-Gross A, Novak N, Kraft S, Bieber T (2001) Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 107:345-52
30. Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B (2005) Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol174:2778-86
31. Renkl A, Berod L, Mockenhaupt M, Idzko M, Panther E, Termeer C et al.(2004) Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int J Mol Med13:203-9
32. Ruwisch L, Schafer-Korting M, Kleuser B (2001) An improved highperformance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. Naunyn Schmiedebergs Arch Pharmacol 363:358-63
33. Sanna MG, Liao J, Jo E, Alfonso C, Ahn MY, Peterson MS (2004) Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem279:13839-48
34. Sanna MG, Wang S-K, Gonzalez-Cabrera PJ, Don A, Marsolais D, Matheu MP et al. (2006) enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol2:434-41
35. Schuppel M, Kurschner U, Kleuser U, Schafer-Korting M, Kleuser B (2008) Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P(2) receptor subtype. J Invest Dermatol 128:1747-56
36. Seo EY, Park GT, Lee KM, Kim JA, Lee JH, Yang JM (2006) Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol126:1187-9
37. Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S et al. (2005) FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 79:1553-60
38. von Wenckstern H, Zimmermann K, Kleuser B (2006) The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. Arch Immunol Ther Exp 54:239-51
39. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-7